Timken to Invest $35 Million in Steel Plant Upgrades

The Timken Company (NYSE: TKR) announced that it will invest approximately $35 million to install a high-volume, in-line forge press at its Faircrest rolling mill facility in Canton, Ohio.

This investment comes on the heels of the $50-million commitment in capital improvements initiated at the end of 2010 at the company's other steel facilities in Canton. The investments reflect the significant increase in demand Timken has seen for its high-performance steel across all markets.

Slated to begin operation in early 2013, the addition of the in-line forge press will generate value by increasing capacity, lowering costs through improved yield, expanding product capabilities to meet ultrasonic specifications that are more demanding and reducing cycle times for larger products.

"This open-die in-line press will be the first step of the forge-rolled process for all Faircrest products." said Tom Moline, vice president of manufacturing. "Adding this step prior to rolling will provide better yield and production efficiencies to significantly improve our operations."

The investment will provide particular value to customers in markets where Timken's high-performance steel products are most critical to performance in extreme operating conditions, such as oil and gas, heavy machinery, wind energy and power generation.

"We are making this next investment with the needs of our customers foremost in mind," said Sal Miraglia, Jr., president of Timken's Steel Group. "In turn, this will contribute substantially to our long-term competitiveness, which is critical to jobs and performance."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.